Justia Weekly Writers’ Picks: Hands Off My Double Helix
Assoc. for Molecular Pathology v. Myriad Genetics, Inc., United States Supreme Court (6/13/13) Drugs & Biotech, Patents Myriad obtained patents after discovering the precise location and sequence of the BRCA1 and BRCA2 genes, mutations of which can dramatically increase the risk of breast and ovarian cancer. The discovery enabled Myriad to develop medical tests for detecting mutations for assessing cancer…
